The relationship between healthy lifestyle behaviors and the incidence of IBS.
Illumina shakes up executive team, lowers 2023 outlook
By the numbers Q2 Revenue: $1.18 billion 1% increase year-over-year Q2 Net loss: $234 million Year-ago net loss: $535 million DNA sequencing provider Illumina